Cancer Research UK and AstraZeneca have announced that they are opening a new centre in the UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.
Synbiosis, a long-established, expert manufacturer of automated microbiological systems, is pleased to announce its ProtoCOL 3 automated colony counter is being used at a major teaching hospital in London.
